Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2019;4(1):1635.DOI: 10.25107/2474-1663-v4-id1635

Characteristics of Adult Glioblastoma in Kuwait

Anwar Ghanim Al Banaw, Sarah Talib Hussain and Kenneth Chukwuka Katchy

Department of Medical Laboratory Sciences, Kuwait University, KuwaitDepartment of Medical Laboratory, Al-Sabah Hospital, Kuwait

*Correspondance to: Kenneth Chukwuka Katchy 

 PDF  Full Text Research Article | Open Access

Abstract:

Introduction: Classification of Glioblastoma (GBM) into primary (p-GBM) and secondary (s-GBM) is based on IDH1 status. This study aims at evaluating selected biomarkers and clinical characteristics of adult GBM in Kuwait and establishing guidelines for case selection for DNA sequencing. Methods: Archived blocks of 100 GBM initially diagnosed in the Histopathology Unit, AlSabah Hospital between 2009 and 2016 in patients aged ≥ 20 years were retrieved and used for Immunohistochemistry (IHC) for wild-type and mutant IDH1, p53 and EGFR. Patients’ characteristics, presenting symptoms and duration, number of lesions, and tumor anatomic location and extent were extracted from the surgical records. Results: S-GBM comprises 10%, spares patients aged ≥ 60 years, has a mean age of 40.9 years, significant association with young age (<50 years) and an exclusive lobar distribution with a predilection for frontal lobe (60%). P-GBM has a mean age of 50.7 years and a more varied anatomic distribution. In 2%, IHC is negative for both wild-type and mutant IDH1. About 38% and 34% are p53+ and EGFR+. Significantly, 80% of s-GBM and 33% of p-GBM are p53+. EGFR+ is observed in 20% s-GBM and below the age of 35 years. EGFR+ s-GBM is located only in the frontal lobe. EGFR-/p53+, EGFR+-/p53-, EGFR+/p53+, and EGFR-/p53- phenotypes form 27%, 23%, 11% and 39% of all GBM respectively. Symptoms lasted for <3 months in 83%. Only 1% of these have s-GBM. About 13% have multiple lesions. Conclusion: Factors precluding DNA sequencing include patient’s age (≥ 60 years), multiple lesions, short duration of symptoms and EGFR+/p53- phenotype. IHC for wild-type IDH1 is unnecessary for GBM investigation.

Keywords:

Glioblastoma; IDH1; p53; EGFR; Kuwait

Cite the Article:

Al Banaw AG, Hussain ST, Katchy KC. Characteristics of Adult Glioblastoma in Kuwait. Clin Oncol.2019;4:1635 .

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Examination of the Efficacy of Fulvestrant 500 mg Targeting Estrogen Receptor-Positive Postmenopausal Metastatic Breast Cancer: Prospective Observational Study (PerSeUS BC03 Study)
 Abstract  PDF  Full Text
Regional Recurrence of Breast Cancer in Ipsilateral Intramammary Lymph Node Six Months after Breast Conserving Surgery
 Abstract  PDF  Full Text
View More...